An observational study in Spinal Cord Injuries, sponsored by University of Minnesota. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-18.
Sponsored by University of Minnesota · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Spinal Cord Injuries by University of Minnesota — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Minnesota.
Among the 15 studies in Spinal Cord Injuries by University of Minnesota, this one is one of 2 that started in 2024, is one of 3 observational ones, and was the 14th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →7 of the 15 studies in Spinal Cord Injuries by University of Minnesota are open now, in 1 country. Recruiting first, the newest first:
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 18+
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 22+
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 1
First in 2015; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 80 is above the median of 60 across 333 observational studies indexed under Spinal Cord Injuries.
Median enrollment 38 across the 12 interventional studies, 113 across the 3 observational. Of the 8 that completed or were terminated, 2 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Minnesota is the lead sponsor of 1,219 studies on the registry; 199 are open to participants now.
Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.
4 of the studies in Spinal Cord Injuries by University of Minnesota that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03026816University of MinnesotaEpidural Stimulation After Neurologic Damage | 2027-01 |
| NCT06140355University of MinnesotacHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury | 2027-01-31 |
| NCT07029802University of MinnesotaDevelopment of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury | 2027-06-15 |
| NCT05741788University of MinnesotaThe Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain | 2027-10-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 15 studies in Spinal Cord Injuries by University of Minnesota, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is twofold: (1) Develop a new evaluation scale for mental body representations (MBR, i.e., body awareness and visuospatial body maps) for adults with spinal cord injury (SCI) with and without neuropathic pain. (2) Assess the psychometric properties of usability, reliability, and validity of the new evaluation scale This is a cross-sectional observational study design. For Aim 1, this study will involve initial item generation for a novel MBR evaluation scale for SCI through email communication, and individual interviews proctored remotely through Zoom, or, if preferred by the participant, in-person. For Aim 2, the study will include a Zoom call for consenting and questionnaires, as well as an in-person visit where participants will be tested with the new SCI-BodyMap evaluation scale, and a questionnaire asking about the usability and satisfaction of the new evaluation scale.
For all adults with SCI in this study: 18+ years old, participants with an incomplete or complete SCI of ≥ 1 year, medically stable, able to read and understand English, having access to the internet/iPad/computer/phone and willing to come in for an in-person testing at the University of Minnesota.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Control group
SCI group
Exclusion Criteria:
SCI group
Other: No intervention
Other: No intervention
This is an observational study
Reliability of the scale
Inter-rater reliability of the new SCI-BodyMap scale (scores from two physical or occupational therapists testing the same participants) will be evaluated with Kappa and ICC.
Time frame: 1 week
Validity of the scale
Convergent validity of the newly developed SCI-BodyMap scale for SCI will be tested with Spearman rho correlations between the new MBR scale and the Revised Body awareness scale, Multidimensional Assessment lnteroceptive Awareness-2 (MAIA- 2), lowest, average and highest neuropathic pain levels with the Numeric Pain Rating Scale (NPRS), and the NINOS-COE SCI Functional lndex/Assistive Technology Scale (SCI/Fl-AT).
Time frame: 1 week
establish the minimal detectable difference (MDD)
The Minimal Detectable Difference (MOD) will be calculated using the standard error of measurement.
Time frame: 1 week
QQ-10 scale, to assess the usability of the new MBR scale.
This will be complemented by open-ended questions about the scale from the point of view of the participant with SCI and the therapists who evaluated the participant with the new scale.
Time frame: 1 week
SCI-related symptoms (Penn Spasm Frequency Scale
We will assess the frequency and severity of spasms (Penn Spasm Frequency Scale),
Time frame: 1 week
SCI-related symptoms (BARQ-R)
We will assess body awareness related to the participant's perception of tension in the body (BARQ-R)
Time frame: 1 week
SCI-related symptoms (MAIA-2)
We will assess interoceptive awareness (MAIA-2).
Time frame: 1 week
Physical functioning.
We will measure function related to basic mobility, self-care, fine motor function, and ambulation (NINOS-COE SCI/Fl-AT)
Time frame: 1 week
Started Nov 2024 (actual). Primary completion is estimated for Jun 2027, 30 months after the start.
Of 124 non-industry observational studies under Spinal Cord Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 74. This study's planned 30 months is below that.
Counting every sponsor, half of 135 studies reached it within 39 months; a quarter within 16 and three quarters within 82.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.